OS
OncoSil Medical Ltd
OSL.AX · ASX
$1.00 -5.66% (-$0.06)
1M -20.30%
Market Cap $32.7M
P/E Ratio -
Div. Yield -
ROE 211.94%
Piotroski F-Score Moderate
4/9Valuation
9 /100
Expensive P/S 19.43x
P/B 6.55x
P/E N/A
Growth
78 /100
Growing Rev. growth 66.10%
Book val. growth 20.33%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 367.72%
Net margin 644.53%
Op. margin 855.64%
Quality
2 /100
Poor ROIC 218.71%
ROE 211.94%
ROA 105.32%
Debt
66 /100
Moderate Debt/Equity 0.00x
Current ratio 1.77x
Int. coverage -858.22x
Stability
16 /100
Unstable Beta 1.23x
Rev. volatility 48.76%
EPS volatility 14,727.89%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o OSL.AX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Nigel Lange
Employees
6
Headquarters
Macquarie Park
Prihajajoči dogodki
02 MAR.
Earnings
Upcoming earnings report